Re-engineering the Immune Response to Metastatic Cancer: Antibody-Recruiting Small Molecules Targeting the Urokinase Receptor.
Angew Chem Int Ed Engl
; 55(11): 3642-6, 2016 Mar 07.
Article
in En
| MEDLINE
| ID: mdl-26879524
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Urokinase-Type Plasminogen Activator
/
Antibodies
/
Neoplasm Metastasis
Limits:
Humans
Language:
En
Year:
2016
Type:
Article